Positional integratomic approach in identification of genomic candidate regions for Parkinson's disease
暂无分享,去创建一个
[1] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[2] Rainer Breitling,et al. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments , 2004, FEBS letters.
[3] D. Kleinjan,et al. Long-range control of gene expression: emerging mechanisms and disruption in disease. , 2005, American journal of human genetics.
[4] N. Wood,et al. Molecular pathogenesis of Parkinson's disease. , 2005, Human molecular genetics.
[5] B. Peterlin,et al. Search for sarcoidosis candidate genes by integration of data from genomic, transcriptomic and proteomic studies. , 2009, Medical science monitor : international medical journal of experimental and clinical research.
[6] S. Aizawa,et al. Characterization of the pufferfish Otx2 cis-regulators reveals evolutionarily conserved genetic mechanisms for vertebrate head specification , 2004, Development.
[7] Robert Gentleman,et al. Using GOstats to test gene lists for GO term association , 2007, Bioinform..
[8] J Khan,et al. DNA microarray technology: the anticipated impact on the study of human disease. , 1999, Biochimica et biophysica acta.
[9] Jianhe Peng,et al. Proteomic analysis of increased Parkin expression and its interactants provides evidence for a role in modulation of mitochondrial function , 2009, Proteomics.
[10] Bassem A. Hassan,et al. Gene prioritization through genomic data fusion , 2006, Nature Biotechnology.
[11] Joyce A. Mitchell,et al. Using literature-based discovery to identify disease candidate genes , 2005, Int. J. Medical Informatics.
[12] J. Kordower,et al. Etiology of Parkinson's disease: Genetics and environment revisited , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[13] P. Robinson,et al. The Human Phenotype Ontology: a tool for annotating and analyzing human hereditary disease. , 2008, American journal of human genetics.
[14] Yan Liu,et al. Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders. , 2006, Journal of Alzheimer's disease : JAD.
[15] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..
[16] S. Bhushan,et al. Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: a proteomic approach. , 2009, Clinica chimica acta; international journal of clinical chemistry.
[17] Mariza de Andrade,et al. High-resolution whole-genome association study of Parkinson disease. , 2005, American journal of human genetics.
[18] F. Middleton,et al. Integrating genetic, functional genomic, and bioinformatics data in a systems biology approach to complex diseases: application to schizophrenia. , 2007, Methods in molecular biology.
[19] Jing Chen,et al. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization , 2009, Nucleic Acids Res..
[20] 中尾 光輝,et al. KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .
[21] Peilin Jia,et al. A multi-dimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case , 2009, Bioinform..
[22] Patrick Cahan,et al. Meta-analysis of microarray results: challenges, opportunities, and recommendations for standardization. , 2007, Gene.
[23] A. Schedl,et al. Aniridia-associated translocations, DNase hypersensitivity, sequence comparison and transgenic analysis redefine the functional domain of PAX6. , 2001, Human molecular genetics.
[24] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[25] E. Birney,et al. Reactome: a knowledgebase of biological pathways , 2004, Nucleic Acids Research.
[26] R. Verhaak,et al. A distal single nucleotide polymorphism alters long-range regulation of the PU.1 gene in acute myeloid leukemia. , 2007, The Journal of clinical investigation.
[27] Damian Smedley,et al. BioMart – biological queries made easy , 2009, BMC Genomics.
[28] Cornelius J Werner,et al. Proteome analysis of human substantia nigra in Parkinson's disease , 2008, Proteome Science.
[29] Dorothea K. Thompson,et al. DNA Microarray Technology , 2005 .
[30] Sean R. Davis,et al. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor , 2007, Bioinform..
[31] Ralf Herwig,et al. Meta-Analysis Approach identifies Candidate Genes and associated Molecular Networks for Type-2 Diabetes Mellitus , 2008, BMC Genomics.
[32] Peter J Park,et al. Improving identification of differentially expressed genes in microarray studies using information from public databases , 2004, Genome Biology.
[33] Bart De Moor,et al. A guide to web tools to prioritize candidate genes , 2011, Briefings Bioinform..
[34] Z. Wszolek,et al. Genetics of Parkinson disease and essential tremor. , 2010, Current opinion in neurology.
[35] Sonja W. Scholz,et al. Genome-wide genotyping in Parkinson's disease and neurologically normal controls: first stage analysis and public release of data , 2006, The Lancet Neurology.
[36] Á. Jónasdóttir,et al. A genome wide linkage disequilibrium screen in Parkinson’s disease , 2005, Journal of Neurology.
[37] V. McKusick. Mendelian Inheritance in Man and Its Online Version, OMIM , 2007, The American Journal of Human Genetics.
[38] Andrew D. Johnson,et al. Bmc Medical Genetics an Open Access Database of Genome-wide Association Results , 2009 .
[39] Rainer Breitling,et al. RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis , 2006, Bioinform..
[40] Yan Wang,et al. Proteomic Identification of a Stress Protein, Mortalin/mthsp70/GRP75 , 2006, Molecular & Cellular Proteomics.
[41] R. Shukla,et al. Blood proteome profiling in case controls and Parkinson's disease patients in Indian population. , 2007, Clinica chimica acta; international journal of clinical chemistry.
[42] Allan I. Levey,et al. Oxidative Modifications and Down-regulation of Ubiquitin Carboxyl-terminal Hydrolase L1 Associated with Idiopathic Parkinson's and Alzheimer's Diseases* , 2004, Journal of Biological Chemistry.
[43] B. Bergamasco,et al. Proteome analysis of human substantia nigra in Parkinson's disease , 2004, Proteomics.
[44] E. Lehman. Epidemiology of neurodegeneration in American-style professional football players , 2013, Alzheimer's Research & Therapy.
[45] M. Orešič,et al. Pathways to the analysis of microarray data. , 2005, Trends in biotechnology.